---
title: "SNGX.US (SNGX.US) — 相关新闻"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/SNGX.US/news.md"
symbol: "SNGX.US"
name: "SNGX.US"
parent: "https://longbridge.com/zh-CN/quote/SNGX.US.md"
datetime: "2026-03-15T22:18:43.980Z"
locales:
  - [en](https://longbridge.com/en/quote/SNGX.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNGX.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNGX.US/news.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/SNGX.US/news.md) | [繁體中文](https://longbridge.com/zh-HK/quote/SNGX.US/news.md)


# SNGX.US (SNGX.US) — 相关新闻

### [Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Products Regulatory Agency | SNGX Stock News](https://longbridge.com/zh-CN/news/278546003.md)
*2026-03-10T03:30:35.000Z*
> Soligenix Announces SGX945 Receives Promising Innovative Medicine Designation from the UK Medicines and Healthcare Produ

### [Soligenix Provides Shareholder Update on Rare Disease Pipeline](https://longbridge.com/zh-CN/news/275812846.md)
*2026-02-12T21:45:32.000Z*
> Soligenix (SNGX) provided a shareholder update on February 12, 2026, detailing progress in its rare disease pipeline, in

### [Soligenix Showcases Rare Disease Pipeline and Market Potential in New Corporate Presentation](https://longbridge.com/zh-CN/news/271950396.md)
*2026-01-08T14:36:19.000Z*
### [Soligenix reports Phase IIa SGX945 trial data for Behçet’s disease](https://longbridge.com/zh-CN/news/270290059.md)
*2025-12-19T10:23:49.000Z*
> Soligenix reported positive Phase IIa trial results for SGX945 in treating Behçet's disease, showing reduced ulcers and 

### [Alliance Global Partners Sticks to Its Buy Rating for Soligenix (SNGX)](https://longbridge.com/zh-CN/news/270266966.md)
*2025-12-19T07:25:58.000Z*
> Alliance Global Partners' analyst James Molloy reiterated a Buy rating for Soligenix (SNGX) with a price target of $10.0

### [Soligenix Psoriasis Trial Extension Shows Better Outcomes With New Gel](https://longbridge.com/zh-CN/news/270050898.md)
*2025-12-17T18:23:00.000Z*
> Soligenix announced positive Phase 2a extension results for SGX302 gel in psoriasis treatment, showing improved skin sco